The complexities of SARS-CoV-2 serology

Lancet Infect Dis. 2020 Dec;20(12):1350-1351. doi: 10.1016/S1473-3099(20)30699-X. Epub 2020 Sep 23.

Authors

Catherine F Houlihan¹, Rupert Beale²

Affiliations

¹ University College London Hospitals, NHS Foundation Trust, London, UK; University College London, London, UK. Electronic address: c.houlihan@ucl.ac.uk.
² University College London, London, UK; The Francis Crick Institute, London, UK.

No abstract available

MeSH terms

Adaptive Immunity
Antibodies, Neutralizing / blood
Antibodies, Viral / blood
Asymptomatic Infections
COVID-19 / blood
COVID-19 / diagnosis*
COVID-19 / immunology
COVID-19 Serological Testing* / methods
COVID-19 Serological Testing* / standards
Coronavirus Nucleocapsid Proteins / immunology
Humans
Phosphoproteins / immunology
Prognosis
SARS-CoV-2 / immunology
SARS-CoV-2 / isolation & purification*
Sensitivity and Specificity
Spike Glycoprotein, Coronavirus / immunology

Substances

Antibodies, Neutralizing
Antibodies, Viral
Coronavirus Nucleocapsid Proteins
Phosphoproteins
Spike Glycoprotein, Coronavirus
nucleocapsid phosphoprotein, SARS-CoV-2
spike protein, SARS-CoV-2